<style face="normal" font="default" size="100%">Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context</style>

Drupal-Bibcite

31<style face="normal" font="default" size="100%">Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context</style><style face="normal" font="default" size="100%">Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context</style>